Tumor Necrosis Factor Inhibitors

The ACR’s annual Great Debate featured spirited arguments made for and against the use of janus kinase inhibitors before biologic therapy in the setting of methotrexate failure in rheumatoid arthritis.

Keeping pace with the worldwide “deluge” of clinical trial developments pertaining to COVID-19 can be a full-time job, according to a presenter at the 2020 Association of Women in Rheumatology National Conference.